Decreased OGN expression has been observed in a variety of different cancers, including gastric cancer [39], colorectal adenoma [40], squamous cervical and vaginal cancer [41], invasive ductal breast carcinoma [42], and laryngeal carcinoma [43]. This evidence concerns the gene OGN and invasive ductal breast carcinoma.